Deubiquitylating enzymes and drug discovery: emerging opportunities

JA Harrigan, X Jacq, NM Martin… - Nature reviews Drug …, 2018 - nature.com
More than a decade after a Nobel Prize was awarded for the discovery of the ubiquitin–
proteasome system and clinical approval of proteasome and ubiquitin E3 ligase inhibitors …

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

J Mandal, P Mandal, TL Wang, IM Shih - Journal of biomedical science, 2022 - Springer
Chromatin remodeling is an essential cellular process for organizing chromatin structure into
either open or close configuration at specific chromatin locations by orchestrating and …

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application

H Gao, J Yin, C Ji, X Yu, J Xue, X Guan… - Journal of Experimental …, 2023 - Springer
Tumors have evolved in various mechanisms to evade the immune system, hindering the
antitumor immune response and facilitating tumor progression. Immunotherapy has become …

[HTML][HTML] Emerging role of ubiquitination in the regulation of PD-1/PD-L1 in cancer immunotherapy

X Hu, J Wang, M Chu, Y Liu, Z Wang, X Zhu - Molecular Therapy, 2021 - cell.com
A growing amount of evidence suggests that ubiquitination and deubiquitination of
programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) play crucial roles in the …

From discovery to bedside: targeting the ubiquitin system

IE Wertz, X Wang - Cell chemical biology, 2019 - cell.com
The ubiquitin/proteasome system is a primary conduit for selective intracellular protein
degradation. Since its discovery over 30 years ago, this highly regulated system continues to …

Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities

D Cheasley, A Nigam, M Zethoven… - The Journal of …, 2021 - Wiley Online Library
Low‐grade serous ovarian carcinoma (LGSOC) is associated with a poor response to
existing chemotherapy, highlighting the need to perform comprehensive genomic analysis …

Post-translational modifications of deubiquitinating enzymes: expanding the ubiquitin code

Y Wang, F Wang - Frontiers in pharmacology, 2021 - frontiersin.org
Post-translational modifications such as ubiquitination play important regulatory roles in
several biological processes in eukaryotes. This process could be reversed by …

Advances in deubiquitinating enzyme inhibition and applications in cancer therapeutics

AM Antao, A Tyagi, KS Kim, S Ramakrishna - Cancers, 2020 - mdpi.com
Since the discovery of the ubiquitin proteasome system (UPS), the roles of ubiquitinating
and deubiquitinating enzymes (DUBs) have been widely elucidated. The ubiquitination of …

Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer

A Jaiswal, K Murakami, A Elia… - Proceedings of the …, 2021 - National Acad Sciences
Triple-negative breast cancer (TNBC) is a breast cancer subtype that lacks targeted
treatment options. The activation of the Notch developmental signaling pathway, which is a …

The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment

Y Wang, X Liu, W Huang, J Liang, Y Chen - Pharmacology & therapeutics, 2022 - Elsevier
Alterations in protein ubiquitination and hypoxia-inducible factor (HIF) signaling both
contribute to tumorigenesis and tumor progression. Ubiquitination is a dynamic process that …